Calendar of events

April 24 – 26, 2023 | Amsterdam, Netherlands

Supercharge the Clinical Translation of Efficacious Neoantigen Vaccines & Immunotherapies for Patients in Need

The 6th Annual Neoantigen Summit Europe returns to Amsterdam, as the only summit in Europe dedicated to advancing exclusive tumour antigen discovery and personalised therapeutic development within the world of immunotherapy.

• Examine critical factors for successful translation of personalised therapies into the clinic with Geneos Therapeutics, Curvac, Transgene, Nykode Therapeutics and Immunetune
• Enhance various methods to increasing the precision accuracy of identifying neoantigens with The Netherlands Cancer Institute and Precision BioLogic
• Delve into the how to overcome specific challenges in vaccine manufacturing for targeting neoantigens with BioNTech

Join 150+ experts at the forum, including Beacon’s Cancer Vaccine Research Lead, Megan Taylor, as they navigate validation of neoantigen targets and review methodologies/technologies to support with translating neoantigen-based studies effectively to the clinic.

April 25 – 27, 2023 | Boston, MA

2022 was another great year for cell engager antibody therapies, and since the approval of Tecytinib, 2023 looks like it will be the year for cell engagers!

The 5th Cell Engager Summit returns to Boston as the only industry-led meeting bringing together 80+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference workshops to delve into the biggest challenges cell engager therapeutics face. Breaking into the solid tumor, preventing CRS and maximizing the quality of insights we gain from preclinical modeling.

Join your colleagues, including our Bispecific Research Lead, Shailee Patel, at the most comprehensive cell engager event, leaving no stone unturned, this highly focused meeting covers everything translational and clinical in greater depth and detail than any before it.